The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.

• Hoofdauteurs: Myra Hardy (Auteur), Josaia Samuela (Auteur), Mike Kama (Auteur), Meciusela Tuicakau (Auteur), Lucia Romani (Auteur), Margot J Whitfeld (Auteur), Christopher L King (Auteur), Gary J Weil (Auteur), Anneke C Grobler (Auteur), Leanne J Robinson (Auteur), John M Kaldor (Auteur), Andrew C Steer (Auteur)
• Formaat: Boek
• Gepubliceerd in: Public Library of Science (PLoS), 2020-03-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Lymphatic filariasis has remained endemic in Fiji despite repeated mass drug administration using the well-established and safe combination of diethylcarbamazine and albendazole (DA) since 2002. In certain settings the addition of ivermectin to this combination (IDA) remains a safe strategy and is m...